references - shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/8467/18/19_references.pdf ·...

338

REFERENCES

1. Kuchekar B.S, Khadatare A.M & Sachin C.I. “Forensic Pharmacy”.

7th edn, Nirali Prakashan, 2008. PP. 5.1.

2. Skoog D.A, Holler F.J & West D.M. “Fundamentals of Analytical

Chemistry”. 7th edn, Saunders College Publications, 1996. PP. 1-3.

3. Christian G.D. “Analytical chemistry”. 4th edn, Amazon

Publishers, 1986. PP. 1-2.

4. Sharma B.K. “Analytical chemistry”. 6th edn, Goel publication Co.,

1983. PP. 1-10.

5. Jeffery G.H, Bassat J, Mendham J, & Denny R.C. “Vogels textbook

of Quantitative Chemical Analysis”. 5th edn, Longman Publication,

1989. PP. 3.

6. Sethi P.D. “Quantitative Analysis of Drugs in Pharmaceutical

formulations”. 3rd edn, CBS Publishers, 1997. PP. 50-64.

7. Wolff M.E. “Burger’s Medicinal Chemistry”. 4th edn, Wiley Inter

sicnece, 1981. PP.3-10.

8. Doserge R.F. “Wilson and Gisvold’s text book of organic medicinal

and pharmaceutical chemistry”. 8th edn., Lippincott company,

1982. PP. 2-26.

9. Pickering W.E. “Modern analytical chemistry”. Marcel Dekker Inc,

1975. PP. 1-3.

10. William O Foye. “Principles of medicinal chemistry”. 3rd edn,

Varghese Publication, 1989. PP. 109, 667 & 973, 1984.

11. Beckett A.H & stenlake J.B. “Practical Pharmaceutical Chemistry”.

4th edn, Cambridge University Press, 1988. PP. 275-325.

12. http://en.wikipedia.org/wiki/UV-Visible spectroscopy.

13. Willard Merrit and Dean Settle. “Instrumental methods of

analysis”. 6th edn, CBS Publications, 1997. PP. 281.

339

14. Jeffery G.H., Basset J & Denny R.C. “Vogel’s Textbook of

Quantitative Chemical Analysis”. 5th edn, Longman Publications,

London, 1989, PP. 212-225.

15. Ewing G.W & Raymond P.W. “Analytical Instrumentation”. 2nd

edn, Marcel Dekker Inc, 1997. PP. 1123-1140.

16. Thomas E.Beesley, Benjamin Buglio & Raymond P.W.Scott

“Quantitative Chromatograpic Analysis”. Marcel Dekker Inc, 2001.

PP. 12.

17. Krstulovic A.M. & Brown R.P. “Reversed-Phase High Performance

Liquid Chromatography Theory, Practice and Biomedical

Applications”. John Wiley and sons Ltd., 1982. PP. 126.

18. Francis Rouessac & Annick Rouessac. “Chemical Analysis”. John

Wiley and sons Ltd., 1999. PP. 58-69.

19. Frank A.Settle. “Hand Book of Instrumental Techniques for

Analytical Chemistry”. Prentice Hall PTR, 1997. PP. 34-63.

20. Hong, D.D. & Shah, M., “Development and Validation of HPLC

stability-indicating assays, In: Drug Stability: Principles and

Practices”. Marcel Dekker Inc, 2000. PP. 329–384.

21. Synder L.R., Kirkland J.J. & Glajch, J.L., “Practical HPLC Method

Development”. John Wiley and sons Ltd., 1997. PP. 234-264, 295,

705

22. Connors, K.A., Amidon, G.L. and Stella, V.J., “Chemical Stability of

Pharmaceuticals”. John Wiley and sons Ltd., 1986. PP. 248-263.

23. FDA, Guidance for Industry: “Stability Testing of Drug Substances

and Drug Products” (Draft guidance). Rockville, MD, 1998.

24. WHO, Guidelines for “Stability Testing of Pharmaceutical Products

Containing Well Established Drug Substances in Conventional

Dosage Forms”. Technical Report Series 863, Geneva, 1996,

PP. 65–79.

25. Center for Drug Evaluation and Research (CDER),

http://www.fda.gov/cder/ guidance/index.htm.

340

26. United States Pharmacopeia 23rd edn, The United States

pharmacopeia convention, Rockville, MD, 1995, PP. 1982-1984.

27. ICH, Validation of analytical procedures, “Definition and

terminology, Q2 A”. IFPMA, Geneva. 2003.

28. ICH, Validation of analytical procedures: “Methodology, Q2 B”.

IFPMA, Geneva. 2003. www.ich.org.

29. Guidance for industry, “Bio-analytical method Validation”, US

Department of Health and Human services, Food and Drug

Administration, Centre for drug evaluation and Research,

Rockville, 2001. http://www.fda.gov/cder/guidance/425fnl.pdf.

30. Shah Y.I., Paradkar A.R. & Dhyagnde M.G. “Introduction to

Biostatistics and computer science”. 1st edn, Nirali Prakashan,

1996. PP. 63-70, 97-103.

31. Bolten S. “Pharmaceutical Statistics Practical and clinical

Applications”. 2nd edn, Marcel Dekker Inc, 1990. PP. 285-290.

32. Budawari S. “The Merck Index”. 13th edn, Merck and Co. Inc.,

2001. PP. 868.

33. http://www.drugbank.ca/drugs/DB00973.

34. http://en.wikipedia.org/wiki/Ezetimibe.

35. British Pharmacopoeia, Vol. II. Controller of her Majesty’s

Stationary office, 2000. PP. 1535.

36. Vijayvergia R, Sridhar G & Grover A. “Ezetimibe: A novel

cholesterol absorption inhibitor”. Drug Bulletin, 29(1), 2000, PP.

35-43.

37. Lennernas H & Fager G., “Pharmacodynamic and

pharmacokinetics of the HMG- CoA reductase inhibitors”. Clin

Pharmacokinet, 32, 1997. PP. 403-425.

38. Moffat A.C. Osselton D.M. & widdop B. “Clarke’s analysis of drugs

and Poisons”. 3rd edn, Pharmaceutical Press, 2004.

341

39. Brunton L.L, Lazo J.S & Parker K.L, “Goodman and Gilman’s The

Pharmacological basis of Therapeutics”. 11th edn, Mc Graw Hill

Co., 2006.


2001. PP. 148.


42. http://en.wikipedia.org/wiki/Simvastatin.


2001. PP. 8181.

44. Riley M.R., Kastrup E.K., & Hebel S.K. “Facts and comparisons”.

55th edn, Missouri, USA, 2001, PP.1167.

45. Prous J.R., “Drugs of the future”, 23, 1998, PP.106-107.


47. http://en.wikipedia.org/wiki/Rabeprazole.

48. United States Pharmacopeia 24th edn, The United States

pharmacopeia convention, 2000, PP. 1219.


50. http://en.wikipedia.org/wiki/Ondansetron.

51. European Pharmacopoeia; council of Europe Strasburg, 3rd edn,

1997, PP. 778-780.

52. The Physician Desk Reference, 56th edn, Medical Economics,

Thomson Healthcare: 2002, PP. 1703.

53. Anthony M & Sorkin EM. “Ondansetron an update of its

therapeutic use in chemotherapy-induced and post operative

nausea and vomiting”. Drugs, 45, 1993. PP. 931-52.

54. British Pharmacopoeia, Vol. I, London, Controller of her Majesty’s

Stationary office, 2000. PP. 40.


2001; PP.578.


57. http://en.wikipedia.org/wiki/Domperidone.

342

58. Indian Pharmacopoeia, Vol ІІ. The Indian Pharmacopoeia

commission, 2007. PP. 1158.


2001. PP. 777.


61. http://en.wikipedia.org/wiki/Gatifloxacin.

62. Syed MR, Nadia MSA & Mansour ME. “Evaluation of effects of

ciprofloxacin and gatifloxacin on neurotransmitter levels on cortex

and hippocampus”. Afr. J. Pharm. Pharmacol., 5(8): 2011.

PP. 993-1005.


2001. PP. 1803.


65. http://en.wikipedia.org/wiki/Moxifloxacin.

66. Gandhimathi M, Dhanya K.N, Natarajan B & Ravi T.K. “Interaction

study of moxifloxacin and lomefloxacin with co administered

drugs”. Pak. J. Pharm. Sci, 3: 2011, PP. 339-343.


2001. PP. 1557.


69. http://en.wikipedia.org/wiki/Sparfloxacin.

70. Vyas U, Desai T & Shah C. “Evaluation of sparfloxacin eyedrops in

the management of conjuctival and corneal infections”. J. Indian

Med. Assoc, 100(6): 2002, PP. 398-9.

71. Ethan Rubinstein. “History of quinolones and their side effects”.

Int. J. Exp. Clinc. Chemother, 47: 2001, PP. 3-8.


2001. PP. 1213.


74. http://en.wikipedia.org/wiki/Ofloxacin.

343

75. United States Pharmacoepia. 24th edn, The United States

pharmacoepial convention, 2004. PP.1335.

76. British Pharmacopoeia, British pharmacopoeia commission office,

2003. PP. 357.

77. European Pharmacopoeia; 5th edn, council of Europe, 2005,

PP. 2131.

78. Osman C, Cosar B, Yuksel T, Umit Y, Nursabah E B & Atilla B.

“Aqueous humour levels of topically applied ciprofloxacin and

ofloxacin in the same subjects”. Eye, 1999, (13), PP. 656-59.


80. http://en.wikipedia.org/wiki/Ciprofloxacin.


2001. PP. 389.


commission, 2007. PP.189.

83. United States Pharmacoepia. The United States pharmacoepial

convention. 24th edn, 2004. PP. 3141.


1996, PP. 949.

85. Freeman CD, Nicolau DP, Belliveau PP & Nightingale CH.

“Lomefloxacin clinical pharmacokinetics”. Clin. Pharmacokinet.,

1993, 25 (1). PP. 6-19.

86. Yamada M, Mochizuki H, Yamada K, Kawai M & Mashima Y.

“Aqueous humor levels of topically applied levofloxacin,

norfloxacin, and lomefloxacin in the same human eyes”. J.

Cataract Refract Surg., 2003. 29 (9), PP. 1771-5.


88. http://en.wikipedia.org/wiki/Lomefloxacin.


commission, 2007. PP.1005-1007.


344

91. http://en.wikipedia.org/wiki/Dexamethasone.

92. United States Pharmacoepia. 23rd edn, The United States

pharmacoepial convention. 1995. PP. 472-473.


1996. PP. 498.

94. Tripathi KD. “Essentials of medical pharmacology”. Jaypee

Brothers Ltd, 2008. PP. 217-218.


2006. PP. 1327.

96. Indian Pharmacopoeia. Vol ІІ. Published by The Indian

Pharmacopoeia commission. 200. PP. 615.


pharmacoepial convention. 1995. PP.1277.


99. http://en.wikipedia.org/wiki/Prednisolone.

100. Falagas ME, Grammatikos AP & Michalopoulos A. “Potential old

generation antibiotics to address current need for new antibiotics”.

Expert Rev Anti Infect Ther 2008. 6 (5), PP. 593–600.


102. http://en.wikipedia.org/wiki/chloramphenicol.


pharmacoepial convention, 1995. PP. 3138.

104. Indian Pharmacopoeia. Vol І. The Indian Pharmacopoeia

commission, 2007. PP. 160.

105. Budawari S. “The Merck Index” 12th edn, Merck and Co. Inc.,

1996. PP. 344.

106. Wang L & Asghanejad M. “Second derivative UV-Spectroscopic

determination of simvastatin inits tablet dosage form”. J. Pharm.

Biomed. Anal., 21(6), 2000. PP. 1243-8.

345

107. Tan L, Yang L.L, ZhangX, Yuan Y.S & Ling S.S. “Determination of

simvastatin in human plasma by high performance liquid

chromatography”. Se Pu., 18(3), 2000. PP. 232-4.

108. Jemal M, Ouyang Z & Powell M.L. “Direct injection LC-MS-MS

method for high throughput simultaneous quantification of

simvastatin and simvastatin acid in human plasma”. J. Pharm.

Biomed. Anal., 15(2-3), 2000. PP. 323-40.

109. Barret B, Huclova J, BorkeDohalsky V, Nemec B & Jelinek L.

“Validated HPLC-MS-MS method for simultaneous determination

of simvastatin and simvastatin hydroxyl acid in human plasma”.

J. Pharm. Biomed. Anal., 41(2), 2006. PP. 517-26.

110. Senthamil selvan P & Pal T.K, “Chromatography tandem mass

spectrometry method for simultaneous quantification of metaprolol

succinate and simvastatin in human plasma”. J. Pharm. Biomed.

Anal., 49, 2009. PP. 780-785.

111. Nilesh J, Ruchi J, Hemant S, Sharad P & Deepak Kumar J.

“Spectrophotometric method for simultaneous estimation of

simvastatin and ezetimibe in bulk drug and its combined dosage

form”. Int. J. Pharm. Pharm. Sci., 1(1), 2009. PP. 170-175.

112. Effat S & Masoud A. “Development and validation of derivative

spectrophotometric method for simultaneous determination of

ezetimibe and simvastatin”. E. J. Chem., 7(S1), 2010. PP. 197-

S202.

113. Basha S.J, Naveed S.A, Tiwari N.K, Shashikumar D, Muzeeb S et

al. “Concurrent determination of ezetimibe and its phase I and II

metabolites by HPLC with UV detection: Quantitative application to

various in-vitro metabolic stability studies and for quatitative

estimation in bile”. J. Chromatogr B Analyt Biomed Life Sci.,

15; 853(1-2), 2007. PP.88-96.

114. Sistla, Tata V.S, Kashyap Y.V, Chandrasekar D & Diwan P.V.

“Development and validation of reverse phase HPLC method for the

346

determination of ezetimibe in pharmaceutical dosage form”.

J. Pharm. Biomed. Anal., 15; 39(3-4), 2000. PP. 517-22.

115. Imran M, Singh R.S & Chandran S, “Stability indicating ultraviolet

spectroscopic method for the estimation of ezetimibe and

carvedilol”. Pharmazie. 61(9), 2006. PP.766-9.

116. Olivera P.R, Brum Junior L, Fronza M, Bernardi L.S, Masiero

S.M.K & Dalmora S.L., “Development and validation of liquid

chromatography- tandem mass spectrometry method for the

determination of ezetimibe in human plasma and pharmaceutical

formulations”. Chromatographia., 63(7-8),2009. PP. 315-320.

117. Godse V.P, Deodhar M.N, Bhosale A.V, Sonawane R.A, Sakpal P.S,

Borkar D.D & Bafana Y.S. “Simultaneous spectrophotometric

estimation of ezetimibe and atorvastatin in pharmaceutical dosage

form”. Asian J. Res. Chem., 2(1), 2009. PP. 86-89.

118. Rajput S.J and Raj H.A., “Simultaneous spectroscopic estimation

of ezetimibe and simvastatin in tablet dosage form”. Indian. J.

Pharm. Sci., 2007. PP. 759-762.

119. Vishnu P.C & Nikalje A.P. “Simultaneous estimation of ezetimibe,

atorvastatin and fenofibrate in pharmaceutical formulations by RP-

LC-PDA”. Pharm. Anal. Acta., 1(2), 2010. PP. 1-5.

120. Garcia C.V, Sippel J, Steppe M & Schpoval E.E.S. “Development

and validation of derivative spectrophotometric method for the

determination of rabeprazole sodium in pharmaceutical dosage

forms”. J. Chromatogr B., 693(12), 1997. PP. 399-406.

121. Kulkarni V.L & Mahulikar P.P. “Estimation of rabeprazole sodium

in tablet dosage form by rapid isocratic reverse phase high

performance liquid chromatography using volatile buffer additives”.

J. Sci. Ind. Res., 65, 2006. PP. 992-994.

122. Lohe R.W, Surse P.B, Kale M.K, Barethiya P.R, Kasture A.V & Lohe

S.W. “Spectrophotometric methods for simultaneous estimation of

347

rabeprazole and diclofenac from combined tablet dosage form”.

Asian J. Res. Chem. 1(1), 2008. PP. 26-28.

123. Preeti G, Umamaheswari R.B, Pakhi R, Dangi Y.S & Jain N.K.

“Simultaneous estimation of rabeprazole sodium and amoxicillin

trihydrate”. Indian J. Pharm. Sci., 2005. PP. 380-384.

124. Heralgi R.V, Simpi C.V, Kalyane N.V & Karajgi S.V. “Simultaneous

spectrophotometric estimation of rabeprazole sodium and itopride

hydrochloride in capsule formulations”. Asian J. Pharm., 2008.

PP. 148-149.

125. Pillai S & Singhvi I. “Quantitative estimation of itopride

hydrochloride and rabeprazole sodium from capsule formulation”.

Indian J. Pharm. Sci., 70(7), 2008. PP. 658-661.

126. Suganthi A, Sofia J & Ravi T.K. “Simultaneous HPTLC

determination of rabeprazole and itopride hydrochloride from their

combined dosage form”. Indian J. Pharm. Sci., 70(3), 2008.

PP. 366-368.

127. Koufopantelis P, Georgakakou S, Kazanis M, Giagnis C, Margeli A

et al, “Direct injection liquid chromatography/positive ion

electrospray ionization mass spectrometric quantification of

methotrexate, folinic acid, folic acid and ondansetron in human

serum”. J. Chromatogr. B. analyt. Technol. Biomed. Life Sci.,

877(30), 2009. PP. 3850-6.

128. Raval P.B, Manisha P, Wadher S.J & Yeole P.G. “A validated

HPTLC method for determination of ondansetron in combination

with omiprazole and rabeprazole in solid dosage forms”.


129. Ke L, Xiaojian D, Dafang Z & Xiaoyan C., “Quantitative

determination of ondansetron inhuman plasma by enantioselective

liquid chromatography-tandem mass spectrometry”.

Chromatographia, 65(11-12), 2007. PP. 743-748.

348

130. Shirish R.P, Patel L.J, Yogeshwar P & Nimesh D.P. “Development

and validation of analytical method for the determination of

rabeprazole and ondansetron in pharmaceutical dosage forms by

reverse phase HPLC”. Int. J. Chem. Tech. Res. 2(3), 2010. PP.

1531-1536.

131. Michelle D, Suzanne L & Gilles C. “High resolution liquid

chromatographic method using ultraviolet detection for

determination of ondansetron in human plasma”. J. Chromatogr

B., 864(1-2), 2008. PP. 129-136.

132. Sradhanjali P, Choudhury A.A, Kar R.K & Barik B.B.

“Specrophotometric method for the of ondansetron hydrochloride”.


133. Kalirajan R, Anandarajagopal K, Seena M.M, Gowramma B, Jubie

S & Suresh B. “Simultaneous determination of rabeprazole and

domperidonein dosage forms by RP-HPLC”. Rasayan J. Chem.,

1(2), 2008. PP. 232-35.

134. Shweta S.S, Nilesh D.D, Vijay Y.J, Santosh R. T & Santosh V.G.

“Spectrophotometric simultaneous determination of rabeprazole

sodium and domperidone in combined tablet dosage form”.

Eur. J. Anal. Chem., 3(2), 2008. PP. 236-244.

135. Patel A.H, Patel J.K & Patel K.N., “Development and validation of

derivative spectrophotometric method for simultaneous estimation

of domperidone and rabeprazole sodium in bulk and dosage

forms”. Int. J. Pharm. Sci., 2(1), 2010. PP. 464-469.

136. Patel B.H, Suhagia B.N, Patel M.M & Patel J.R. “Determination of

pantaprazole, rabeprazole, esomeprazole domperidone and itopride

in pharmaceutical products by reverse phase liquid

chromatography using single mobile phase”. J. Pharm. Biomed.

Anal., 41(2), 2006. PP. 358-65.

137. Shahid Ali M, Mohsin G & Aamer R.K. “Stability indicating

simultaneous determination of domperidone, methyl paraben and

349

propyl paraben by high performance liquid chromatography”.

J. Chromatogr B., 720(1-2), 1998. PP. 251-55.

138. Lakshmi S & Anilkumar V. “Simultaneous HPLC estimation of

omiprazole and domperidone from tablets”, Indian J. Pharm. Sci.,

69(5), 2007. PP. 674-676.

139. Prasanna Reddy B. “Simultaneous HPLC estimation of

pantaprazole and domperidone from tablets”. Int. J. Chem. Tech

Res., 1(2), 2009. PP. 275-277.

140. Sowmya G, Gandhimathi M, Ravi T.K & Sireesha K.R. “HPTLC

method for the determination of gatifloxacin in human plasma”.


141. Saleh A.D, Syed N.A & Muhammed M.H. “Development and

validation of HPLC method for the determination of gatifloxacin

stability in human plasma”, J. Pharm. Biomed. Anal. 41(1), 2006.

PP. 251-255.

142. Hoang A.N, Jean G, Boubakar B, Claudine Q & Marie C.S.,

“Simultaneous determination of Levofloxacin, gatifloxacim and

moxifloxacin in serum by liquid chromatography with column

switching”. J. Chromatogr B., 810(1), 2004. PP. 77-83.

143. Brain R.O, Michael B.K & Kevin M.S. “Determination of gatifloxacin

in human serum and urine by high performance liquid

chromatography with ultraviolet detection”. J. Chromatogr B.,

798(1), 2003. PP. 167-173.

144. Venugopal K & Raendra N.S. “New, simple and validated UV

spectrophotometric methods for the estimation of gatifloxacin in

bulk and formulations”. II Farmaco., 60(11-12), 2005. PP. 906-

912.

145. Karthick V, Michael G.B & James T.S. “Determination of

gatifloxacin in human plasma by liquid chromatography/

electrospry tandem mass spectrometry”. Rapid Comm. Mass Spec.,

15(12),2001. PP. 915-19.

350

146. Xiashi Z, Aigin G & Suhai Y. “Fluorescence probe enhanced

spectofluorimetric method for the determination of gatifloxacin in

pharmaceutical formulations and biological fluids”. Spectro Chim.

Acta Part A: Mole. Biomolec. Spec., 69(2), 2008. PP. 478-82.

147. Bhanubhai N.S, Shailesh A.S, Ishwarisinh S.R, Haresh M.P,

Dinesh R.S & Bhavin P. M. “Determination of gatifloxacin and

ornidazole in tablet dosage forms by high performance thin layer

chromatography”. Analt. Sci., 22(5), 2006. PP. 743

148. Vandana & A.K. Chaudhary, “A validated HPTLC method for

estimation of moxifloxacin hydrochloride in tablets”.

African J. Pharm. Sci. Pharm., 1, 2010. PP. 74-84.

149. K.V. Prasada Rao, L.D. Srinivas, P. Ravikumar, P. Yesupadam & G.

Prabhakar. “A note on the estimation of moxifloxacin in bulk and

pharmaceutical formulations by precipitation reagents”. E. J.

chem., 3(10), 2006. PP. 5-8.

150. Lalitha Devi M & Chandrasekar K.B. “A validated specific stability

indicating RP-LC method for moxifloxacin and its related

substances”. Chromatographia. 69(9-10), 2009. PP. 993-99.

151. Karthick V, Michel G.B & James T.S. “Determination of

moxifloxacin in human plasma by liquid chromatography

electospray ionization tandem mass spectrometry”. J. Pharm.

Biomed. Anal., 30(4), 2002. PP. 961-968.

152. Aleksandra L.D, Milena J.S & Predrag D. “Optimization and

validation of the direct HPLC method for the determination of

moxifloxacin in human plasma”. J. Chromatogr B., 844(1), 2006.

PP. 104-11.

153. Kumudavalli M.V, Ramasubbiah P, Saravanan C, Kumar M &

Margret C. “Method development and validation for estimation of

moxifloxacin HCl in tablet dosage form by RP-HPLC method”.

Pharm. Anal. Acta., 1(1), 2010. PP. 333-36.

351

154. Sharma M.C & Smitha S. “UV-densitometric determination of of

sparfloxacin and its application to the assay in pharmaceutical

dosage forms”. J. Optoelec. Biomed. Mat., 2(4), 2010. PP. 191-95.

155. Najma S, Saeed AM, Somia G, Mahwish A & Sana S.

“Simultaneous determination of sparfloxacin and commonly used

H2 receptor antagonists by RP-HPLC: application to in vitro drug

interactions”. Med Chem Res., 2011. Online first.

156. Keumhan N, Kwang K, Tae C.J & Wonku K. “Quantitative

determination of sparfloxacin in rat plasma by liquid

chromatography/tandem mass spectrometry”. Biomed.

Chromatogr., 2010, 24(11):1199-1202.

157. Cao S.X, Zhang J.Y, Ji X.M & Liu H.M. “Quantitative analysis of

sparfloxacin injection by high performance liquid

chromatography”. Se Pu., 19(5), 2001. PP. 454-6.

158. Herida R.N. M & Elfrides E.S.S. “Development and validation of

non-aqueous titration with perchloric acid to determine

sparfloxacin in tablets”. Eur. J. Pharm. Biopharm., 52(2), 2001.

PP. 227-29.

159. Herida R.N. & Elfrides E.S.S. “Spectrophotometric determination of

sparfloxacin in pharmaceutical formulations using bromothymol

blue”. J. Pharm. Biomed. Anal., 26(3), 2001. PP. 501-504.

160. Rele RV & Warkar CB. “Simultaneous determination of

ciprofloxacin hydrochloride and dexamethasone in ophthalmic

solution by reversed phase high performance liquid

chromatography”. Asian J Res Chem., 3(3), 2010. PP. 673.

161. Manuela T.M, Nuno J.G, Nuno B.S & Jose A.M. “Simple high

performance liquid chromatographic assay for the determination of

ciprofloxacin in human plasma with ultraviolet detection”.

J. Chromatogr. B., 755(1-2), 2001. PP. 305-309.

162. Scholl H, Schmidt K & Weber B. “Sensitive and selective

determination of pictogram amounts of ciprofloxacin and its

352

metabolited in biological samples using high performanance liquid

chromatography and photothermal post column derivatization”.

J. Chromatogr. B., 416, 1987. PP. 305-309.

163. Isabel P.R, Gertrudis P.P & Antonio M.D. “solid phase UV-

spectrophotometric method for determination of ciprofloxacin”.

Michrochemical J. 77(1), 2004. PP. 79-84.

164. Han W.S, Li-Qing L & Xue Y.C., “Flow injection enhanced

chemiluminescence method for determination of ciprofloxacin in

pharmaceutical preparations and biological fluids”. Anal. Bioanal.

Chem., 384(6), 2006. PP. 1314-1319.

165. Novakovic J, Nesmerak K, Nova H & Filka K. “HPTLC method for

the determination and purity control of ciprofloxacin HCl in coated

tablets”. J. Pharm. Biomed. Anal., 25(5-6), 2001. PP. 957-64.

166. Chen Y, Zhou Y.P, Tan D, Deng J & Xu L. “Simultaneous

determination of ciprofloxacin hydrochloride and dexamethasonein

compound ciprofloxacin hydrochloride ear drops by HPLC”.

J. Lionang University., DOI: cnki:ISSN:1000-5846.0.2006-04-010.

167. Lu W, Guo H & Zeng F. “Content determination of compound

ofloxacin ear drops by HPLC simultaneously”.

DOI: CNKI:SUN:ZGYA.0.2005-10-028.

168. Tan R & Mingxiu L.G. “Simultaneous determination of ofloxacin

and dexamethasone sodium phosphate in compound ofloxacin

nasal drops by HPLC”. west china J. Pharm. Sci., DOI: CNKI: ISSN:

1006-0103.0.1999-01-020.

169. Tang Kai Z, Fu Xiu J & Li G., “Simultaneous HPLC determination

of three components of compound ofloxacin ear drops”.

Chinese J Hospital Pharm. DOI: CNKI:SUN:ZGYZ.0.2002-01-012.

170. Wu Y, Zhao Y & Mao M.Y. “Improved HPLC determination of

ofloxacin capsules”. Anhui Medical and Pharm. J.,

DOI: CNKI: ISSN: 1009-6469.0.2003-05-033.

353

171. Kapil S.K, Santosh V.G, Padmanabh B.D & Nilesh V.G. “A simple

and sensitive RP-HPLC method for simultaneous estimation of

cefexime and ofloxacin in combined tablet dosage form”.

Int J Pharm Pharm Sci. 3(1), 2011. PP. 46-48.

172. Dhandapani B, Thirumoorthy N, Shaik H.R, Ramakotaiah M &

Anjaneyulu N., “Method development and validation for the

simultaneous estimation of ofloxacin and ornidazole in tablet

dosage form by RP-HPLC”. Int. J. Pharm. Sci. Res., 2010, 1(1):78-

83.

173. Vipul P.R, Devanand B.S., “Simultaneous HIGH-performace liquid

chromatographic determination of nitazoxanide and ofloxacin in

tablet formulation”. Eurasian J. Chem. 4(3), 2009. PP. 304-310.

174. Rajasekaran A, Jayakar B, Dhanalakshmi S, Deepalakshmi M &

Beulah V. “Visible spectrophotometric method for the

determination of lomefloxacin hydrochloride in pharmaceutical

preparations”. Indian J. Pharm. Sci., 60(4), 1998. PP. 236.

175. Sevgi T.U. “Highly sensitive spectrofluorometric determination of

lomefloxacin in spiked plasma, urine and in pharmaceutical

formulations”. European J Med Chem. 44 (9), 2009. PP 3402-05.

176. Fenxi C. X. “An HPLC assay of lomefloxacin in lomefloxacin

hydrochloride eye drops”. Analytical Abstracts. 23 (1), 2004.

PP. 112-113.

177. Joana S, Gilberto A, Ana F, Angelina P, Celeste L & Amilcar F.

“Development and validation of a fast isocratic liquid

chromatographic method for the simultaneous determination of

norfloxacin, lomefloxacin and ciprofloxacin in human plasma”.

Biomed. chromatogr, 25, 2011. PP. 535-41.

178. Maria I. Santoro R.M, Najla M, Kasab, Anil K.S et al. “Quantitative

determination of gatifloxacin, Levofloxacin, lomefloxacin and

pefloxacin fluoroquinolinic antibiotics in pharmaceutical

354

preparations by high performance liquid chromatography”.

J. Pharm. Biomed. Anal., 40(1), 2006. PP. 179-184.

179. Sohan S.Chitlange, Meenal R, Sagar B.W & Dinesh M.S. “Stability

indicating HPLC method for estimation of lomefloxacin

hydrochloride in pharmaceutical dosage forms”.

Int. J. Pharm. Tec. Res., 1(3), 2009. PP. 844-851.

180. Alvarez L, Lopez C, Nunez V & Sguella J. A., “Voltametric behavior

and analytical applications of lomefloxacin an antibacterial

fluoroquinolone”. J. AOAC., 84(3), 2001. PP. 649-58.

181. Chen Q, Zielinski D, Chen J, Koski A, werst D & Nowak S . J.

“A validated stability indicating HPLC method for the

determination of dexamethasone related substances on

dexamethasone coated drug eluting stents”. Pharm. Biomed. Anal.,

48(3), 2008. PP. 732-38.

182. Hyung WK & Donald JD. “Determination of dexamethasone

sodium phosphate in the vitreous by high performance liquid

chromatography”. Korean J opthalmol. 9, 1995. PP. 79-83.

183. Hu Xiang Z, Fei Q & Ding Li G. “Determination of dexamethasone

acetate in cream by colorimetry”. Strait Pharm. J.,

DOI: CNKI:SUN:HAIX.0.1998-02-021.

184. Kazuo M, Yasuji K, Shigeo B, Gene K & Jerome P.S.

“Determination of dexamethasone in human plasma and urine by

electron impact mass spectroscopy”. J. Chromatogr. B., 343, 1985.

PP. 231-237.

185. Spangler M & Mularz E. “A validated stability indicating method for

the assay of dexamethasone in drug substance and drug product

analyses and the assay of preservatives in drug product”.

Chromatographia, 54(5-6), 2001. PP. 329-334.

186. Olga H.H, Manuel J.L, Elisa A.C, Manuel S.A.L & Thea B.A.R.

“Determination of dexamethasone in urine by gas chromatography

355

with negative chemical ionization mass spectrometry”.

J. Chromatogr. B., 788(1), 2003. PP. 137-146.

187. Mahesh N.S & William J.J., “Quantification of dexamethasone and

corticosterone in rat biofluids and fetal tissue using highly

sensitive analytical methods: Assay validation and application to a

pharmacokinetic study”. Biomed. Chromatogr., 21(6), 2007.

PP. 585-597.

188. Abd El M.I, Hesham Salem & Eman Maher.“Spectrophotometric

determination of binary mixtures of prednisolone with some

antibiotics”. Thai J. Pharm. Sci., 30(3-4), 2006. PP. 49-94.

189. Patrica A.W & Edward R.B. “High pressure liquid chromatographic

determination of some corticosteroids in topical pharmaceuticals”.

J. Pharm. Sci., 70(5), 1981. PP. 530–534.

190. Balaji K, Raghunadha Reddy G.V, Madhusudana Reddy T &

Jayarama Reddy S. “Determination of prednisolone,

dexamethasone and hydrocortisone in pharmaceutical

formulations and biological fluid samples by voltametric

techniques using β-cyclodextrin modified carbon paste electrode”.

Afr. J. Pharm. Pharmacol., 2(8), 2008. PP. 157-166.

191. Ashok R, Prakash P.P & Tamil Selvan R. “Develpoment and

validation of analytical method for estimation of prednisolone in

bulk and tablets using UV-Visible spectroscopy”. Int. J. Pharm.

Pharm. Sci., 3(4): 2011. 184-86.

192. Ali M.S, Ghori M, Saeed A., “Simultaneous determination of

ofloxacin, tetrahydrozoline hydrochloride, and prednisolone acetate

by high-performance liquid chromatography”. J. Chromatogr.Sci.,

40, 2002. PP. 429-33.

193. Matin S.b & Amos B. “Quantitative determination of prednisone

and prednisolone in human plasma using GLC and chemical

ionization mass spectrometry”. J. Pharm. Sci., 67(7), 1978. PP.

923-26.

356

194. Aburuz J. M & Heaney J.M, “Simple liquid chromatographic

method for the rapid simultaneous determination of prednisolone

and cortisol in plasma and urine using hydrophilic lipophilic

balanced solid phase extraction cartridges”. J. Chromatogr. B.,

798(2), 2003. PP. 193-201.

195. Valeria F & Kathleen M.T. “Determination of glucocorticoids,

prednisone, prednisolone, dexamethasone and cortisol in human

serum using liquid chromatography coupled to tandem mass

spectrometry”. J. Chromatogr. B., 802(2), 2004. PP. 329-38.

196. Yu Zi C, Zhang F, Liu K & Cai W. “simultaneous determination of

chloramphenicol and betamethasone in xinfu cream by HPLC”.

West Chaina J. Pharm. Sci., DOI: CNKI:SUN:HXY.0.2005-01-033.

197. Shadoul W.A, Gad Kariem, Adam M.E & Ibrahim K.E.E.

“Simultaneous determination of dexamethasone sodium phosphate

and chloramphenicol in ophthalmic solutions”. Int. J. Chem Sci.

Tech., 1(2), 2011. PP. 60-69.

198. Iqbal MS, Shad MA, Ashraf MW, Bilal M & Saeed M. “Development

and validation of an HPLC method for the determination of

dexamethasone, dexamethasone sodium phosphate and

chloramphenicol in presence of each other in pharmaceutical

preparation”. Chromatographia., 64(3/4), 2006. PP. 219-222.

199. Xio- Bin C, Yin-Liang W & Ting Y. “Simultaneous determination of

clenbuterol, chloramphenicol and diethylstilbestrol in bovine milk

by isotope dilution ultraperformance liquid chromatography–

tandem mass spectrometry”. J. Chromatogr. B., 879(11-12), 2011.

PP. 799-803.

200. Cerkvenik- Flajs V. “Performance charecterestics of an analytical

procedure for determining chloramphenicol residues in muscle

tissue by gas chromatography-electron capture detection”.

Biomed. Chromatogr. 20(10), 2006. PP. 985-92.

357

201. Basilio Morelli. “Spectophotometric assay for Chloramphenicol and

some derivatives in pure form and formulations”. J. Pharm.

Biomed. Anal., 5(6), 1987. PP. 577-83.

202. Satinsky D, Chocholous P, Salabova M & Solich P. “Simple

determination of chloramphenicol in a pharmaceutical preparation

using a short monolithic column coupled to a sequential injection

system”. J. Sep. Sci., 29(16), 2006. PP. 2494-99.

203. Chitlange S.S, Chaturvedi K.K & Wankhede S.B. “Development and

validation of spectrophotometric and HPLC method for the

simultaneous estimation of salbutamol sulphate and prednisolone

in tablet dosage form”. J. Anal. Bioanal. Techniques., 2(1), 2011.

PP.117.

204. Hong W, Ynhui W & Zhongxi Z. “Fragmentation study of

simvastatin and lovastatin using electrospray ionization tandem

mass spectrometry”. J. Mass Spectrom., 36, 2001. PP. 58-70.

references - shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/8467/18/19_references.pdf ·...

Documents